#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14666	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2437	739.5	0	.	n	.	0	A69G	SNP	69	69	A	489	489	G	990	G,A,T	697,288,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14666	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2437	739.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1870	1870	T	939	T,G	938,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14666	16S	1529	1529	99.87	16S.l6.c17.ctg.1	2437	739.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1604	1604	C	962	C,G	961,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25134	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3930	795.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1888	1888	A	1046	A	1046	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25134	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3930	795.6	0	.	n	.	0	C1344T	SNP	1344	1344	C	1895	1895	T	1025	T,C	586,439	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25134	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3930	795.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2522	2522	C	820	C	819	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25134	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3930	795.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2596	2596	A	788	A,C	787,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25134	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3930	795.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3148	3148	C	892	C,G,A	890,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	2238	folP	852	852	99.88	folP.l6.c4.ctg.1	2022	138.0	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1061	1063	AAA	208;207;211	A,G;A;A	207,1;207;211	.	.
folP.WHO_X_01360c	folP.WHO_X_01360c	1	1	539	2238	folP	852	852	99.88	folP.l6.c4.ctg.1	2022	138.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1292	1294	AGC	201;202;205	A,G;G;C	200,1;202;205	folP.WHO_X_01360c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4774	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3773	157.4	0	.	p	.	0	H193N	NONSYN	577	579	CAC	1088	1090	AAC	196;196;196	A;A,C;C	196;195,1;196	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4774	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3773	157.4	0	.	p	.	0	K261del	DEL	781	781	A	1292	1292	A	168	A,C	166,2	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4774	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3773	157.4	1	SNP	p	S91F	0	.	.	271	273	TCC	782	784	TCC	176;175;177	T;C;C	176;175;177	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4774	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3773	157.4	1	SNP	p	D95N	0	.	.	283	285	GAC	794	796	GAC	187;186;187	G;A;C,T	187;186;186,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	4774	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3773	157.4	1	SNP	p	D95G	0	.	.	283	285	GAC	794	796	GAC	187;186;187	G;A;C,T	187;186;186,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1870	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1949	119.6	1	SNP	p	G45D	0	.	.	133	135	GGC	801	803	GGC	226;224;223	G;G;C	226;224;223	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	996	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1453	85.4	0	.	n	.	0	A197.	DEL	197	197	A	852	852	A	212	A,C	211,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4996	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3425	182.0	1	SNP	p	D86N	0	.	.	256	258	GAC	802	804	GAC	199;200;201	G;A;C,A	199;199;199,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4996	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3425	182.0	1	SNP	p	S87I	0	.	.	259	261	AGT	805	807	AGT	203;203;204	A;G,T;T	202;201,1;203	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4996	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3425	182.0	1	SNP	p	S87W	0	.	.	259	261	AGT	805	807	AGT	203;203;204	A;G,T;T	202;201,1;203	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4996	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3425	182.0	1	SNP	p	S87R	0	.	.	259	261	AGT	805	807	AGT	203;203;204	A;G,T;T	202;201,1;203	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4996	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3425	182.0	1	SNP	p	S88P	0	.	.	262	264	TCC	808	810	TCC	203;202;203	T,A;C,T;C,G	200,2;200,1;201,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4252	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3211	164.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1767	1769	GGC	228;225;225	G;G;C,A	228;225;224,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4108	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	184.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1465	1467	GCA	247;249;247	G;C;A	247;249;247	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4108	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	184.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1468	1470	ATC	246;246;248	A,G;T,A;C	245,1;245,1;248	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4108	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	184.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1480	1482	GTG	243;244;243	G;T,G;G	243;242,2;243	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4108	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	184.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1480	1482	GTG	243;244;243	G;T,G;G	243;242,2;243	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4108	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	184.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1984	1986	ACC	233;235;235	A,T,C;C;C	231,1,1;235;235	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4108	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	184.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2038	2040	GCG	213;212;210	G;C;G	213;212;210	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4108	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	184.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2038	2040	GCG	213;212;210	G;C;G	213;212;210	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4108	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	184.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2161	2163	GGC	208;207;207	G;G;C,T	208;207;206,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4108	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	184.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2170	2172	GGC	207;207;208	G,A;G,T;C	206,1;205,2;208	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4108	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2764	184.9	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2188	2190	CTG	211;212;210	C;T,C,G;G	211;210,1,1;210	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5718	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3425	207.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1782	1784	CCG	215;218;219	C;C;G	215;218;219	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2478	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2449	126.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	895	895	C	188	C	188	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	20;23;25	T;T;A	20;23;25	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	63;63;63	C;A;T	63;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	63;63;63	A;G;T	63;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	63;63;63	T;A;C	63;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	2;2;2	G;A;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	2;2;2	A;T;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	2;2;2	T;C;G	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	1;1;1	G;C;C	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	226	90.27	porB1a.l15.c17.ctg.1	378	31.9	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	1;1;1	G;T;T	1;1;1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	100	95.0	porB1a.l15.c17.ctg.3	182	47.4	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	54;51;47	A;C;G	54;51;47	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	288	porB1a	984	100	95.0	porB1a.l15.c17.ctg.3	182	47.4	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	19;18;14	C;A;A	19;18;14	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1621	222.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	540	542	GAA	268;263;261	G;A;A,T	268;263;260,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1621	222.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	828	830	GAT	263;263;263	G;A,C;T,G	263;262,1;261,2	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1621	222.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	951	953	TCA	283;284;288	T,G;C;A	282,1;284;288	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1621	222.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1080	1082	GTC	255;255;253	G,T;T;C	254,1;255;253	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1621	222.2	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1092	1094	TCT	254;254;258	T;C,T;T	254;253,1;258	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1621	222.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1410	1412	GCA	251;253;251	G,T;C;A	250,1;253;251	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1621	222.2	1	SNP	p	G120K	1	.	.	358	360	AAG	786	788	AAG	256;258;258	A;A,G;G,T	256;257,1;256,2	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1621	222.2	1	SNP	p	A121D	1	.	.	361	363	GAC	789	791	GAC	261;265;263	G,T;A,G,C;C,A	260,1;263,1,1;262,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1621	222.2	1	SNP	p	D121N	0	.	.	361	363	GAC	789	791	GAC	261;265;263	G,T;A,G,C;C,A	260,1;263,1,1;262,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10484	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5313	246.0	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2239	2241	AAT	266;267;266	A;A;T,G	266;267;265,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1434	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1468	121.8	1	SNP	p	V57M	1	.	.	169	171	ATG	752	754	ATG	244;244;246	A;T;G	244;244;246	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
